Shares of Medicines (MDCO) shoot up 10.4% premarket after the firm settles patent litigation...


Shares of Medicines (MDCO) shoot up 10.4% premarket after the firm settles patent litigation with Teva Parenteral Medicines in relation to generic versions of Angiomax. As part of the agreement, Teva admits two patents asserted in the lawsuit filed by MDCO are valid and enforceable.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs